(Q64931098)

1 July 2019

title

The feasibility of high-dose chemotherapy in breast cancer patients with impaired left ventricular function. (English)

1 reference

1 July 2019

author name string

Rose M

1

1 reference

1 July 2019

Lee FA

2

1 reference

1 July 2019

Gollerkeri A

3

1 reference

1 July 2019

D'Andrea E

4

1 reference

1 July 2019

Psyrri A

5

1 reference

1 July 2019

Bdolah-Abram T

6

1 reference

1 July 2019

Burtness BA

7

1 reference

1 July 2019

publication date

1 July 2000

1 reference

1 July 2019

Bone Marrow Transplantation

published in

1 reference

1 July 2019

volume

26

1 reference

1 July 2019

issue

2

1 reference

1 July 2019

page(s)

133-139

1 reference

1 July 2019

Risk factors for doxorubicin-induced congestive heart failure

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Anthracycline-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cyclophosphamide toxicity. Characterising and avoiding the problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cardiac disturbances during the administration of taxol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

The high-dose sequential (Milan) chemotherapy/PBSC transplantation regimen for patients with lymphoma is not cardiotoxic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Review of tests for monitoring doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702449

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702449

1 reference

1 July 2019

Dimensions Publication ID

1040589987

0 references

1 reference

1 July 2019